News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Cryoport Q1 revenue rose 16% year-over-year.
  • Commercial cell and gene therapy revenue increased 26% year-over-year.
  • Management raised full-year revenue guidance to $192–196 million.
  • Cryoport is positioned as a primary beneficiary of cell and gene therapy commercialization.
  • Trade recommendation: long entry $17.40, stop $14.50, target $30 over ~180 trading days.
  • Q1 results and raised guidance strengthen the bullish case for CYRX equity.

Latest Articles

Brazil Keeps 12% Crude Export Levy in Place for 60 More Days

Brazil Keeps 12% Crude Export Levy in Place for 60 More Days

Brazil's executive foreign trade panel extended a 12% tax on crude oil exports for an additional 60 days, maintaining a temporary levy first introduced in March. The decision, taken by the executive management committee of Camex (Gecex), will be reviewed again in 30 days. The government has tied tax revenue to consumer protection measures and retai…

Ben Bernanke Named to Anthropic's Long-Term Benefit Trust

Ben Bernanke Named to Anthropic's Long-Term Benefit Trust

Anthropic has added Ben Bernanke, Distinguished Fellow at the Brookings Institution and former U.S. Federal Reserve Chair, to its Long-Term Benefit Trust. The independent trust, which supervises how the AI company pursues its public benefit mission, holds powers to appoint board members and advise on AI risks and societal effects. Bernanke joins a …

Ceribell CEO Chao Xingjuan Sells $776K in Stock Under Pre-Arranged Plan

Ceribell CEO Chao Xingjuan Sells $776K in Stock Under Pre-Arranged Plan

Ceribell, Inc. (NASDAQ: CBLL) President and CEO Chao Xingjuan executed a series of transactions on July 7, 2026, selling 39,000 shares of the company's common stock through a Rule 10b5-1 trading plan. The sale generated approximately $776,100 at a weighted average price of $19.90 per share. Concurrently, Ms. Chao exercised stock options to acquire …

FedEx Shares Jump as Analyst Upgrades and Operational Risks Ease

FedEx Shares Jump as Analyst Upgrades and Operational Risks Ease

FedEx stock rose 3.3% to $319.90 in mid-day trading after a wave of analyst upgrades, an improved company-specific outlook and the resolution of a notable labor risk. Upgrades from Barclays and Stephens, a stronger consensus among analysts, the ratification of a pilot contract and recent strategic divestitures combined to bolster sentiment for the …

Fund-Raising Rises While U.S. Direct-Lending Slows Sharply

Fund-Raising Rises While U.S. Direct-Lending Slows Sharply

U.S. private credit firms saw a notable recovery in fundraising for closed-end, North America-focused direct-lending vehicles in the second quarter, yet lending activity by those firms contracted materially over the same period. Data from Preqin and PitchBook/LCD show a divergence between fresh capital entering the asset class and the pace at which…

Velocity Financial Accounting Officer Executes Pre-Arranged Stock Sale

Velocity Financial Accounting Officer Executes Pre-Arranged Stock Sale

Fiona Tam, Chief Accounting Officer at Velocity Financial, Inc. (NYSE:VEL), executed a sale of 68 shares on July 7, 2026, totaling $1,292 at a price of $19.00 per share. This transaction, conducted under a Rule 10b5-1 trading plan adopted on March 14, 2026, leaves Ms. Tam with 48,361 direct shares. The sale price exceeds the current trading price o…

Velocity Financial EVP Jeffrey T. Taylor Sells $41,135 in Common Stock Amidst Mixed Q1 Earnings and Strategic Appointments

Velocity Financial EVP Jeffrey T. Taylor Sells $41,135 in Common Stock Amidst Mixed Q1 Earnings and Strategic Appointments

Jeffrey T. Taylor, Executive Vice President of Capital Markets at Velocity Financial, Inc., executed a sale of common stock on July 7, 2026, totaling $41,135. The transaction involved 2,165 shares sold at $19.00 per share under a Rule 10b5-1 plan adopted in March 2026. This occurs against a backdrop of mixed first-quarter 2026 financial results for…

Meta: The Compute Build Was a Bet, Not a Bust — Time to Buy the Dip

Meta: The Compute Build Was a Bet, Not a Bust — Time to Buy the Dip

Meta's heavy AI compute spending has alarmed some investors, but the balance sheet, cash flow, and early commercial plays (clouding excess capacity) argue the company has optionality. This trade idea outlines a long position with clear entry, stop, and target, backed by fundamental and technical data and a set of realistic catalysts and risks.

Moody's Affirms A3 Rating for Malaysia Sukuk Backed by Government Guarantee

Moody's Affirms A3 Rating for Malaysia Sukuk Backed by Government Guarantee

Moody's has assigned an A3 senior unsecured rating to upcoming US dollar-denominated trust certificates to be issued by Malaysia Sovereign Sukuk Berhad, a special purpose vehicle formed by the Government of Malaysia. The rating mirrors the government's own A3 long-term issuer rating with a stable outlook. Proceeds will be used for Shari'ah-complian…

Stifel Tops JD Power Study for Fourth Straight Year

Stifel Tops JD Power Study for Fourth Straight Year

Stifel Financial Corp. announced that its broker-dealer subsidiary, Stifel, Nicolaus & Company, ranked No. 1 in employee advisor satisfaction in the JD Power 2026 U.S. Financial Advisor Satisfaction Study, marking the fourth consecutive year earning this distinction. Stifel received high scores in leadership, operational support, and marketing, ref…

Strain in US Equity Funding Persists After June Short-Term Rate Spike

Strain in US Equity Funding Persists After June Short-Term Rate Spike

US equity funding markets experienced a sharp rise in short-term financing costs around the June quarter-end, driven by heightened demand for leverage tied to technology and sector-targeted exchange-traded funds. Financing in the equity repurchase market reached roughly 200 basis points above the federal funds rate on June 26, per Morgan Stanley, b…

Google to Add Disclosure Panel Signaling AI Use in Ads

Google to Add Disclosure Panel Signaling AI Use in Ads

Google announced plans to introduce a disclosure panel that will indicate when generative artificial intelligence was used to create or alter advertisements on its platform. The company said the panel - called "How this ad was made" - is part of broader AI transparency steps in its advertising business, though it did not provide timing, format cove…

Egypt's Central Bank Keeps Rates Unchanged as Regional Tensions Persist

Egypt's Central Bank Keeps Rates Unchanged as Regional Tensions Persist

Egypt's monetary policy committee held its key interest rates steady for the third straight meeting, keeping the deposit rate at 19% and the lending rate at 20%. Policymakers cited continued uncertainty from renewed US-Iran strikes and the wider impact on energy markets as a factor in pausing rate cuts. Recent inflation data show a monthly dip in h…

Medallion Financial Gains Modestly After Raymond James Launches Coverage

Medallion Financial Gains Modestly After Raymond James Launches Coverage

Medallion Financial's shares rose about 1.0% in mid-day trading after Raymond James began coverage with a Market Perform rating. The analyst highlighted the company's strong growth profile and scalable operating model, while noting a low P/E, a roughly 5.7% dividend yield and the advantage of an industrial bank charter. An upcoming second-quarter e…

Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease

Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease

Serina Therapeutics announced the completion of sentinel dosing in the first cohort of its Phase 1b registrational trial for SER-252, an investigational treatment for advanced Parkinson's disease. The Safety Monitoring Committee recommended proceeding with additional dosing, and the company expects to complete enrollment and dosing ahead of prior g…